Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 115 found
From 21 References


Asmann et al 2011, Nucleic Acids Res
  Adenocarcinoma Breast
SLC37A1/ABCG1
t(21;21)(q22;q22)

Babiceanu et al 2016, Nucleic Acids Res
  Nonneoplastic epithelial disorder/lesion Bladder
WRB/SH3BGR
t(21;21)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Skin
WRB/SH3BGR
t(21;21)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Thyroid
WRB/SH3BGR
t(21;21)(q22;q22)

Cerveira et al 2006, Neoplasia
  Adenocarcinoma Prostate
TMPRSS2/ERG
t(21;21)(q22;q22)

Clark et al 2007, Oncogene
  Adenocarcinoma Prostate
TMPRSS2/ERG
del(21)(q22q22),t(21;21)(q22;q22)
  Hyperplasia Prostate
TMPRSS2/ERG
del(21)(q22q22),t(21;21)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Prostate
TMPRSS2/ERG
del(21)(q22q22),t(21;21)(q22;q22)

Gu et al 2016, Nat Commun
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERG/DYRK1A
t(21;21)(q22;q22)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1/DSCAM
t(21;21)(q22;q22)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1/DYRK1A
t(21;21)(q22;q22)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
ITSN1/KCNE2
t(21;21)(q22;q22)
B-Lineage

Hermans et al 2006, Cancer Res
  Adenocarcinoma Prostate
TMPRSS2/ERG
t(21;21)(q22;q22)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Uterus, corpus
ABCG1/BACE2
t(21;21)(q22;q22)
  Adenocarcinoma Uterus, corpus
AGPAT3/PDE9A
t(21;21)(q22;q22)
  Adenocarcinoma Liver
AGPAT3/RRP1
t(21;21)(q22;q22)
  Adenocarcinoma Pancreas
BRWD1/WRB
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
C21orf2/UMODL1
t(21;21)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
CHAF1B/DOPEY2
t(21;21)(q22;q22)
  Adenocarcinoma Large intestine
DIP2A/YBEY
t(21;21)(q22;q22)
  Malignant epithelial tumor, special type Uterus, corpus
DNAJC28/GART
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
DYRK1A/KCNJ6
t(21;21)(q22;q22)
  Squamous cell carcinoma Unknown site
DYRK1A/IFNGR2
t(21;21)(q22;q22)
  Adenocarcinoma Kidney
DYRK1A/HUNK
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
ERG/TMPRSS2
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
ERG/SON
t(21;21)(q22;q22)
  Mesothelioma Pleura
EVA1C/TCP10L
t(21;21)(q22;q22)
  Adenocarcinoma Stomach
EVA1C/ABCG1
t(21;21)(q22;q22)
  Adenocarcinoma Breast
EVA1C/MRAP
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
EVA1C/CBR3
t(21;21)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
HLCS/TSPEAR
t(21;21)(q22;q22)
  Adenocarcinoma Breast
ICOSLG/KCNJ6
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
PDE9A/TMPRSS2
t(21;21)(q22;q22)
  Transitional cell carcinoma Bladder
PKNOX1/PDE9A
t(21;21)(q22;q22)
  Squamous cell carcinoma Unknown site
PRMT2/WRB
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
RRP1B/FAM207A
t(21;21)(q22;q22)
  Malignant melanoma Skin
RUNX1/IFNAR1
t(21;21)(q22;q22)
  Adenocarcinoma Oesophagus
SIM2/MORC3
t(21;21)(q22;q22)
  Adenocarcinoma Stomach
SON/IL10RB
t(21;21)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
SPATC1L/DSCR8
t(21;21)(q22;q22)
  Adenocarcinoma Liver
TMEM50B/GART
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
TMPRSS2/MRPS6
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
TMPRSS2/MORC3
t(21;21)(q22;q22)
  Squamous cell carcinoma Unknown site
TMPRSS2/HSF2BP
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
TMPRSS2/PDE9A
t(21;21)(q22;q22)
  Adenocarcinoma Stomach
TMPRSS2/SETD4
t(21;21)(q22;q22)
  Adenocarcinoma Adrenal
TRAPPC10/AGPAT3
t(21;21)(q22;q22)
  Adenocarcinoma Large intestine
TTC3/CBS
t(21;21)(q22;q22)
  Malignant melanoma Skin
UBE2G2/SON
t(21;21)(q22;q22)
  Adenocarcinoma Pancreas
UBE2G2/ABCG1
t(21;21)(q22;q22)
  Adenocarcinoma Pancreas
WRB/ERG
t(21;21)(q22;q22)
  Adenocarcinoma Oesophagus
ZBTB21/TFF1
t(21;21)(q22;q22)

Kim et al 2015, Genes Chromosomes Cancer
  Adenocarcinoma Breast
C2CD2/TFF1
t(21;21)(q22;q22)

Laxman et al 2006, Neoplasia
  Adenocarcinoma Prostate
TMPRSS2/ERG
t(21;21)(q22;q22)

Liu et al 2016, EBioMedicine
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
BRWD1/ETS2
t(21;21)(q22;q22)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
WDR4/PDE9A
t(21;21)(q22;q22)
B-Lineage

McPherson et al 2011, PLoS Comput Biol
  Adenocarcinoma Ovary
SLC37A1/ABCG1
t(21;21)(q22;q22)

Piazza et al 2012, Nucleic Acids Res
  Acute promyelocytic leukemia (FAB type M3)
ETS2/ERG
t(21;21)(q22;q22)

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
IFNAR2/IL10RB
t(21;21)(q22;q22)

Qian et al 2017, Genome Res
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1/ETS2
t(21;21)(q22;q22)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1/PCNT
t(21;21)(q22;q22)
B-Lineage

Reshmi et al 2017, Blood
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1/DSCAM
t(21;21)(q22;q22)
B-Lineage

Robinson et al 2017, Nature
  Adenocarcinoma Breast
RUNX1/ERG
t(21;21)(q22;q22)

The Cancer Genome 2013, N Engl J Med
  Acute myeloblastic leukemia with maturation (FAB type M2)
IFNGR2/GART
t(21;21)(q22;q22)

Tomlins et al 2005, Science
  Adenocarcinoma Prostate
TMPRSS2/ERG
t(21;21)(q22;q22)

Wang et al 2006, Cancer Res
  Adenocarcinoma Prostate
TMPRSS2/ERG
t(21;21)(q22;q22)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Prostate
SCAF4/HLCS
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
PDE9A/SLC37A1
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
TRAPPC10/UBASH3A
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
ERG/KCNJ6
t(21;21)(q22;q22)
  Adenocarcinoma Prostate
EVA1C/CBR3
t(21;21)(q22;q22)
  Squamous cell carcinoma Lung
MORC3/FAM3B
t(21;21)(q22;q22)
  Squamous cell carcinoma Lung
GART/PCP4
t(21;21)(q22;q22)
  Adenocarcinoma Lung
UBE2G2/GART
t(21;21)(q22;q22)
  Adenocarcinoma Lung
DYRK1A/TTC3
t(21;21)(q22;q22)
  Adenocarcinoma Lung
CLIC6/ITSN1
t(21;21)(q22;q22)
  Adenocarcinoma Lung
PDE9A/ABCG1
t(21;21)(q22;q22)
  Adenocarcinoma Lung
WRB/KCNJ15
t(21;21)(q22;q22)
  Astrocytoma, grade I-II Brain
HLCS/YBEY
t(21;21)(q22;q22)
  Astrocytoma, grade I-II Brain
SYNJ1/PDE9A
t(21;21)(q22;q22)
  Adenocarcinoma Lung
PDXK/LCA5L
t(21;21)(q22;q22)
  Adenocarcinoma Lung
BRWD1/HUNK
t(21;21)(q22;q22)
  Adenocarcinoma Lung
DOPEY2/CBR3
t(21;21)(q22;q22)
  Adenocarcinoma Kidney
COL18A1/ADARB1
t(21;21)(q22;q22)
  Adenocarcinoma Kidney
ZBTB21/PFKL
t(21;21)(q22;q22)
  Astrocytoma, grade I-II Brain
TTC3/BRWD1
t(21;21)(q22;q22)
  Astrocytoma, grade I-II Brain
SIM2/KCNJ6
t(21;21)(q22;q22)
  Squamous cell carcinoma Oral cavity
DYRK1A/RUNX1
t(21;21)(q22;q22)
  Squamous cell carcinoma Oral cavity
TIAM1/PCBP3
t(21;21)(q22;q22)
  Squamous cell carcinoma Oral cavity
SIK1/HUNK
t(21;21)(q22;q22)
  Adenocarcinoma Breast
BRWD1/ABCG1
t(21;21)(q22;q22)
  Adenocarcinoma Breast
SYNJ1/C21orf62
t(21;21)(q22;q22)
  Adenocarcinoma Breast
DOPEY2/SH3BGR
t(21;21)(q22;q22)
  Adenocarcinoma Breast
DSCR3/IGSF5
t(21;21)(q22;q22)
  Adenocarcinoma Breast
TRAPPC10/BRWD1
t(21;21)(q22;q22)
  Adenocarcinoma Breast
SLC37A1/PCP4
t(21;21)(q22;q22)
  Adenocarcinoma Breast
SETD4/FTCD
t(21;21)(q22;q22)
  Adenocarcinoma Breast
RCAN1/GART
t(21;21)(q22;q22)
  Adenocarcinoma Breast
DOPEY2/TRPM2
t(21;21)(q22;q22)
  Adenocarcinoma Breast
POFUT2/WDR4
t(21;21)(q22;q22)

NextPage